BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33748490)

  • 21. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.
    Hansen R; Russell RK; Reiff C; Louis P; McIntosh F; Berry SH; Mukhopadhya I; Bisset WM; Barclay AR; Bishop J; Flynn DM; McGrogan P; Loganathan S; Mahdi G; Flint HJ; El-Omar EM; Hold GL
    Am J Gastroenterol; 2012 Dec; 107(12):1913-22. PubMed ID: 23044767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.
    Shen ZH; Zhu CX; Quan YS; Yang ZY; Wu S; Luo WW; Tan B; Wang XY
    World J Gastroenterol; 2018 Jan; 24(1):5-14. PubMed ID: 29358877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis.
    Macfarlane S; Furrie E; Cummings JH; Macfarlane GT
    Clin Infect Dis; 2004 Jun; 38(12):1690-9. PubMed ID: 15227614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls.
    Vigsnæs LK; Brynskov J; Steenholdt C; Wilcks A; Licht TR
    Benef Microbes; 2012 Dec; 3(4):287-97. PubMed ID: 22968374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota transplantation ameliorates active ulcerative colitis.
    Chen HT; Huang HL; Xu HM; Luo QL; He J; Li YQ; Zhou YL; Nie YQ; Zhou YJ
    Exp Ther Med; 2020 Apr; 19(4):2650-2660. PubMed ID: 32256746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low counts of Faecalibacterium prausnitzii in colitis microbiota.
    Sokol H; Seksik P; Furet JP; Firmesse O; Nion-Larmurier I; Beaugerie L; Cosnes J; Corthier G; Marteau P; Doré J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1183-9. PubMed ID: 19235886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation].
    Тикунов АЮ; Морозов ВВ; Швалов АН; Бардашева АВ; Шрайнер ЕВ; Максимова ОА; Волошина ИО; Морозова ВВ; Власов ВВ; Тикунова НВ
    Vavilovskii Zhurnal Genet Selektsii; 2020 Mar; 24(2):168-175. PubMed ID: 33659796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin.
    Klingberg E; Magnusson MK; Strid H; Deminger A; Ståhl A; Sundin J; Simrén M; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2019 Nov; 21(1):248. PubMed ID: 31771630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.
    Forbes JD; Van Domselaar G; Bernstein CN
    Inflamm Bowel Dis; 2016 Apr; 22(4):817-25. PubMed ID: 26937623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case-control study on the association of intestinal flora with ulcerative colitis.
    Tang YH; Liu HC; Song G; Wu TT; Zhao Y; Shi LJ
    AMB Express; 2021 Jul; 11(1):106. PubMed ID: 34264407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients.
    Santoru ML; Piras C; Murgia A; Palmas V; Camboni T; Liggi S; Ibba I; Lai MA; Orrù S; Blois S; Loizedda AL; Griffin JL; Usai P; Caboni P; Atzori L; Manzin A
    Sci Rep; 2017 Aug; 7(1):9523. PubMed ID: 28842640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment.
    Dai L; Tang Y; Zhou W; Dang Y; Sun Q; Tang Z; Zhu M; Ji G
    Front Pharmacol; 2020; 11():620724. PubMed ID: 33628183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host.
    Seishima J; Iida N; Kitamura K; Yutani M; Wang Z; Seki A; Yamashita T; Sakai Y; Honda M; Yamashita T; Kagaya T; Shirota Y; Fujinaga Y; Mizukoshi E; Kaneko S
    Genome Biol; 2019 Nov; 20(1):252. PubMed ID: 31767028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis.
    Petito V; Graziani C; Lopetuso LR; Fossati M; Battaglia A; Arena V; Scannone D; Quaranta G; Quagliariello A; Del Chierico F; Putignani L; Masucci L; Sanguinetti M; Sgambato A; Gasbarrini A; Scaldaferri F
    World J Gastroenterol; 2019 Mar; 25(12):1465-1477. PubMed ID: 30948910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.
    Walujkar SA; Kumbhare SV; Marathe NP; Patangia DV; Lawate PS; Bharadwaj RS; Shouche YS
    World J Microbiol Biotechnol; 2018 May; 34(6):76. PubMed ID: 29796862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL; Wang YD; Wang K; Li JA; Li L
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Study of Intestinal Microbiome in Patients with Ulcerative Colitis and Healthy Controls in Korea.
    Do KH; Ko SH; Kim KB; Seo K; Lee WK
    Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.